AIM Vaccine Co., Ltd. (HKG:6660)
3.670
+0.040 (1.10%)
Jun 23, 2025, 3:59 PM HKT
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
---|---|---|---|---|---|---|
Class II Vaccine | 1.23B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Class I Vaccine | 80.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Freeze-dried Human Rabies Vaccine (Vero Cell) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Freeze-dried Human Rabies Vaccine (Vero Cell) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
HBV Vaccines (Hansenula Polymorpha) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
HBV Vaccines (Hansenula Polymorpha) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Group A, C, Y and W135 MPSV (MPSV4) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Group A, C, Y and W135 MPSV (MPSV4) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Inactivated HAV Vaccines (Human Diploid Cell) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Inactivated HAV Vaccines (Human Diploid Cell) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Research and Development Services | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Research and Development Services Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Mumps Vaccine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Mumps Vaccine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
HFRS Vaccine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
HFRS Vaccine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
---|---|---|---|---|---|---|
China | 1.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -10.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|